- Home
- Â /Â Coherus BioSciences
Coherus BioSciences
Stock Price
$0.7
2024-10-29
Market Capitalization
$85.6 M
2024-10-29
Revenue
$257.2 M
FY, 2023
Coherus BioSciences Summary
Company Summary
- Overview
- Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. It offers immuno-oncology and biosimilar therapy solutions.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Redwood City, CA, US | view all locations
- Website
- https://www.coherus.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Rosh Dias, Chief Medical Officer
Richard L. Hameister, Chief Technical Officer
Theresa Lavallee, Chief Development Officer
Operating MetricsView all
Patent Families
25
FY, 2020
Trials Products Approved
1
FY, 2020
Phase II Trials Products
1
FY, 2020
LocationsView all
2 locations detected
Redwood City, CAÂ HQ
United States
333 Twin Dolphin Dr #600
Camarillo, CA
United States
1000 Avenida Acaso
Coherus BioSciences Financials
Summary Financials
- Revenue (Q3, 2024)
- $70.8M
- Gross profit (Q3, 2024)
- $50.0M
- Net income (Q3, 2024)
- ($10.8M)
- Cash (Q3, 2024)
- $97.7M
- EBIT (Q3, 2024)
- ($6.4M)